5-chloro-6-(4-chloro-phenylamino)-nicotinic acid methyl ester | 951771-57-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 5-chloro-6-(4-chloro-phenylamino)-nicotinic acid methyl ester
• 英文别名: methyl 5-chloro-6-(4-chloroanilino)pyridine-3-carboxylate
• CAS: 951771-57-6
• 化学式: C₁₃H₁₀Cl₂N₂O₂
• 分子量: 297.141
• InChiKey: OIHXYFKPFTXAHU-UHFFFAOYSA-N

物化性质

• 沸点：
  386.6±42.0 °C(Predicted)
• 密度：
  1.411±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  19
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  51.2
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  5-chloro-6-(4-chloro-phenylamino)-nicotinic acid methyl ester 在 水 、 sodium hydroxide 作用下， 以 甲醇 为溶剂， 反应 0.5h， 生成 5-chloro-6-(4-chlorophenylamino)nicotinic acid
  参考文献：
  名称：

  Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activity

  摘要：

  High throughput screening led to the identification of nicotinamide derivative 2 as a structurally novel mGluR5 antagonist. Optimization of the modular scaffold led to the discovery of 16m, a compound with high affinity for mGluR5 and excellent selectivity over other glutamate receptors. Compound 16m exhibits a favorable PK profile in rats, robust anxiolytic-like effects in three different animal models of fear and anxiety, as well as a good PK/PD correlation. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.11.001
• 作为产物：
  描述：

  5,6-二氯烟酸甲酯 、 对氯苯胺 在 palladium diacetate 、 R-(+)-1,1'-联萘-2,2'-双二苯膦 potassium carbonate 作用下， 以 甲苯 为溶剂， 反应 16.25h， 以38%的产率得到5-chloro-6-(4-chloro-phenylamino)-nicotinic acid methyl ester
  参考文献：
  名称：

  WO2007/113276

  摘要：

  公开号：

文献信息

• NOVEL BI-ARYL AMINES
  申请人：Glatthar Ralf

  公开号：US20090286827A1

  公开（公告）日：2009-11-19

  The present invention relates to novel bi-aryl amines of formula (I) and to pharmaceutically acceptable prodrugs, salts, solvates, hydrates, and N-oxides thereof and to pharmaceutical compositions comprising them, methods of their use, and methods of their preparation.

  本发明涉及公式（I）的新型双芳基胺，以及其药学上可接受的前药、盐、溶剂合物、水合物和N-氧化物，以及包含它们的制药组合物、使用方法和制备方法。
• WO2007/113276
  申请人：——

  公开号：——

  公开（公告）日：——
• [EN] NOVEL BI-ARYL AMINES<br/>[FR] NOUVELLES BI-ARYLE AMINES
  申请人：NOVARTIS AG

  公开号：WO2007113276A1

  公开（公告）日：2007-10-11

  [EN] The present invention relates to novel bi-aryl amines of formula (I) and to pharmaceutically acceptable prodrugs, salts, solvates, hydrates, and N-oxides thereof and to pharmaceutical compositions comprising them, methods of their use, and methods of their preparation.
  [FR] La présente invention concerne de nouvelles bi-aryle amines de formule (I) et leurs promédicaments, sels, solvates, hydrates et N-oxydes pharmaceutiquement acceptables, ainsi que des compositions pharmaceutiques les comprenant, leurs procédés d'utilisation et de préparation.
• Piperidyl amides as novel, potent and orally active mGlu5 receptor antagonists with anxiolytic-like activity
  作者：Carsten Spanka、Ralf Glatthar、Sandrine Desrayaud、Markus Fendt、David Orain、Thomas Troxler、Ivo Vranesic

  DOI：10.1016/j.bmcl.2009.11.001

  日期：2010.1

  High throughput screening led to the identification of nicotinamide derivative 2 as a structurally novel mGluR5 antagonist. Optimization of the modular scaffold led to the discovery of 16m, a compound with high affinity for mGluR5 and excellent selectivity over other glutamate receptors. Compound 16m exhibits a favorable PK profile in rats, robust anxiolytic-like effects in three different animal models of fear and anxiety, as well as a good PK/PD correlation. (C) 2009 Elsevier Ltd. All rights reserved.